A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Zeidner, Joshua F., Lin, Tara L., Vigil, Carlos E., Fine, Gil, Yair Levy, M., Nazha, Aziz, Esteve, Jordi, Lee, Daniel J., Yee, Karen, Dalovisio, Andrew, Wang, Eunice S., Bergua Burgues, Juan M., Schriber, Jeffrey, Litzow, Mark R., Frankfurt, Olga, Castillo, Teresa Bernal Del, Bhatt, Vijaya Raj, Bhatnagar, Bhavana, Mehta, Priyanka, Dillon, Richard, Vicente, Maria Vidriales, Anthony, Stephen, Bearss, David, Montesinos, Pau, Douglas Smith, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557202/
https://www.ncbi.nlm.nih.gov/pubmed/34718324
http://dx.doi.org/10.1038/s41408-021-00568-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557202/
https://www.ncbi.nlm.nih.gov/pubmed/34718324
http://dx.doi.org/10.1038/s41408-021-00568-3

Ejemplares similares